Teva Pharmaceuticals, Intel to study Huntington disease progression

JERUSALEM (Reuters) - Teva Pharmaceutical Industries is collaborating with Intel Corp to develop a wearable device and machine learning platform for Huntington disease patients, Teva said on Thursday.